Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 8/20 | 0.56 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.56 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.56 |
| ▸ | LGALS9 | O00182 | 3/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.53 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.53 |
| ▸ | CD69 | Q07108 | 1/20 | 0.50 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13123120 | 0.95 | LGALS3 (0.53) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL27272247 | 0.94 | LGALS3 (0.55) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL17954599 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL13136604 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL16675413 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL10023255 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL17953133 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL13799095 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL15386146 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 | |
| SCHEMBL13784257 | 0.91 | LGALS3 (0.58) | LGALS3LGALS7; LGALS7BLGALS1LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9414967-B2 | Composition, preparation, and use of chitosan shards for biomedical applications | LOMA LINDA UNIVERSITY (US) | 2016-08-16 | — | — | US | disclosed |
| US-9364578-B2 | Hemostatic agent for topical and internal use | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160121021-A1 | COMPOSITION, PREPARATION, AND USE OF CHITOSAN SHARDS FOR BIOMEDICAL APPLICATIONS | UNIV LOMA LINDA (US) | 2016-05-05 | — | — | US | disclosed |
| US-20160082037-A1 | COMPOSITION, PREPARATION, AND USE OF CHITOSAN POWDER FOR BIOMEDICAL APPLICATIONS | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2016-03-24 | — | — | US | disclosed |
| US-20160058904-A1 | CHITOSAN-BASED HEMOSTATIC TEXTILE | NORTH CAROLINA STATE UNIVERSITY | 2016-03-03 | — | — | US | disclosed |
| US-9259357-B2 | Composition, preparation, and use of chitosan shards for biomedical applications | LOMA LINDA UNIVERSITY (US) | 2016-02-16 | — | — | US | disclosed |
| US-20160030025-A1 | VASCULAR WOUND CLOSURE DEVICE AND METHOD | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2016-02-04 | — | — | US | disclosed |
| US-9226988-B2 | Chitosan-based hemostatic textile | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2016-01-05 | — | — | US | disclosed |
| US-20150297783-A1 | COMPOSITION, PREPARATION, AND USE OF CHITOSAN SHARDS FOR BIOMEDICAL APPLICATIONS | NORTH CAROLINA STATE UNIVERSITY | 2015-10-22 | — | — | US | disclosed |
| US-20150086419-A1 | CHITOSAN-BASED HEMOSTATIC TEXTILE | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2015-03-26 | — | — | US | disclosed |
| US-8932521-B2 | Chitosan-based hemostatic textile | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140178446-A1 | HEMOSTATIC AGENT FOR TOPICAL AND INTERNAL USE | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2014-06-26 | — | — | US | disclosed |
| US-8623274-B2 | Chitosan-based hemostatic textile | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2014-01-07 | — | — | US | disclosed |
| US-20120093686-A1 | CHITOSAN-BASED HEMOSTATIC TEXTILE | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2012-04-19 | — | — | US | disclosed |
| US-20120059410-A1 | WOUND CLOSURE DEVICE AND METHOD | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160082037-A1 | COMPOSITION, PREPARATION, AND USE OF CHITOSAN POWDER FOR BIOMEDICAL APPLICATIONS | CHIT1, NCDN, CHIA | LGALS3 1377/4885LGALS7; LGALS7B 1697/4885LGALS1 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.